About MetaDx
MetaDx is a company based in Seoul (South Korea) founded in 2024 by Giup Jang and Chris Kim. MetaDx offers products and services including Tumor Diagnosis Service. MetaDx operates in a competitive market with competitors including CanCan Diagnostics and Muse Microscopy, among others.
- Headquarter Seoul, South Korea
- Founders Giup Jang, Chris Kim
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Metadx Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Korea Investment Accelerator
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MetaDx
MetaDx offers a comprehensive portfolio of products and services, including Tumor Diagnosis Service.
AI-based service for early tumor detection in pets
Funding Insights of MetaDx
Investors in MetaDx
MetaDx has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Korea Investment Accelerator and Yoonmin Creative Investment Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startup acceleration services are provided by Korea Investment Accelerator.
|
Locked | Locked | Locked | |
|
Support is provided for innovative startups and youth entrepreneurship.
|
Locked | Locked | Locked |
Investor details for MetaDx
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MetaDx
Investment portfolio details for MetaDx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MetaDx
Detailed financials for MetaDx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Metadx Comparisons
Peer comparison for MetaDx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MetaDx
MetaDx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CanCan Diagnostics and Muse Microscopy, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Develops blood tests for early detection and monitoring of canine cancer through DNA analysis.
|
|
| Locked | Locked | Locked |
Provides slide-free tissue imaging for rapid digital pathology diagnostics in healthcare.
|
Detailed competitors of MetaDx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Metadx
Complete news archive for MetaDx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MetaDx
MetaDx was founded in 2024.
MetaDx is headquartered in Seoul, South Korea.
Chris Kim is the current CEO of MetaDx. They have also founded this company.
MetaDx was founded in 2024 in Seoul, South Korea, focusing on the veterinary diagnostics sector. AI-powered tools are provided, including CancerVET, which analyzes serum biomarkers to detect tumors in pets. Additionally, VitalVET software is offered to process real-time vital signs from anesthesia hardware, enabling predictions of emergencies, cause analysis, and response recommendations. Operations center on software development for animal health monitoring.
MetaDx's top competitors include CanCan Diagnostics and Muse Microscopy.
MetaDx offers Tumor Diagnosis Service.
MetaDx has 2 investors. Key investors include Korea Investment Accelerator, and Yoonmin Creative Investment Foundation.